Natural Alternatives International Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Natural Alternatives International Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No changes.
No changes.
Largest filed tie
28.00%
of NAII revenue · Undisclosed largest private-label contract manufacturing customer
0.00%
NAII weight · VTI
No thesis.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Annual filing, covered
10-K parsed · Sep 28 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Sep 28 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Natural Alternatives International Inc
1.06
−0.01 · −0.93%
—
Same SIC code · 6
Same SEC industry code: Definium Therapeutics, Inc., Usana Health Sciences Inc, Niagen Bioscience, Inc. and 3 more; no measured co-movers for Natural Alternatives International Inc.
Same SIC code · 6
Same SEC industry code: Definium Therapeutics, Inc., Usana Health Sciences Inc, Niagen Bioscience, Inc. and 3 more; no measured co-movers for Natural Alternatives International Inc.
—
—
Expected move
No implied move.
+2.25%
shares held · 10 largest managers
| Manager | Value | % base | |
|---|---|---|---|
| Caldwell Sutter Capital | $1.2M | 21.89% | −0.11% |
| Dimensional | $802,536 | 14.75% | −5.34% |
| Morgan Stanley | $735,236 | 13.51% | +14.68% |
| Mink Brook | $701,338 | 12.89% | −0.09% |
| Renaissance Technologies | $663,122 | 12.19% | −4.77% |
| Manager | Value | % base | |
|---|---|---|---|
| Caldwell Sutter Capital | $1.2M | 21.89% | −0.11% |
| Dimensional | $802,536 | 14.75% | −5.34% |
| Morgan Stanley | $735,236 | 13.51% | +14.68% |
| Mink Brook | $701,338 | 12.89% | −0.09% |
| Renaissance Technologies | $663,122 | 12.19% | −4.77% |
Bull1
Bear2